ClinicalTrials.gg
CompletedNCT03635476Updated Jan 27, 2021

Survey of Lifelong Food and Nutrition Assistance (LIFANA) in Stroke Patients and Caregivers

An observational study in Stroke, Relatives and Diet Modification, sponsored by Cereneo AG. Completed at 1 site in Switzerland. Per ClinicalTrials.gov, last updated 2021-01-27.

Sponsored by Cereneo AG · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
5
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 216 studies in Stroke with a site in Switzerland — 46 open to participants now, 60 under way, 6 of them phase 3. Stroke · Switzerland.

Enrollment
68th of 69
5 · median 200
Started
2018
with 16 others
Observational
69 of 216
16 open now
Registered
119th of 216
by date
Lead sponsor
6 of 216
Cereneo AG

Among the 216 studies in Stroke with a site in Switzerland, this one is the 68th largest by enrollment of the 69 observational ones that give a count, is one of 17 that started in 2018, is one of 69 observational ones, and was the 119th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

46 of the 216 studies in Stroke with a site in Switzerland are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 216 studies in Stroke with a site in Switzerland, or all of them as a file.
02

Study summary

Many elderly suffer from nutritional problems that can cause (or can be caused by) a number of complications such as weakened immune systems and chronic health conditions (diabetes type 2, high blood pressure, cardiovascular diseases or even osteoporosis).

Through appropriate adjustments in the diets, on the basis of nutritional advice, the burden of established diseases as well as the risks of developing further conditions can be diminished. The goal of our proposed project LIFANA is to develop and evaluate the LIFANA Nutrition Solution to support healthy nutrition.. This may include general preferences, such as culture, taste, and budget, but more importantly automated and personalised nutritional recommendations based on advice provided by professional nutritionists and allergists. This is a national project co-funded by the European Union.

One of the activities of the project is to collect information through a survey with patients. These questions will contribute to creating solutions that can explore the perspectives of patients.

Read the detailed description

Patients will be approached in the clinic by a neurologist and health care professionals. The questionnaire will take place at cereneo. The group will consist of 25 participants and last between 1h. The Survey will be conducted by a clinician who will take notes. Semi-structured discussion guide will be used. With regard to the communication, the moderator will identify factors that will influence communication in a positive or negative way.

The health professionals will perform content analyses on the transcripts; the schema of categories will be oriented towards the research questions, using open questions, directly addressing quiet participants, and handling the discussion guide in a flexible way.

03

Conditions studied

  • Stroke
  • Relatives
  • Diet Modification

Browse trials for

Keywords

  • Stroke Rehabilitation
  • Personalized Nutrition
  • Mobile-Health
  • Stroke
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

stroke patients undergoing rehabilitation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • stroke patients undergoing rehabilitation
  • caregivers of stroke patients

Exclusion criteria

Exclusion Criteria:

  • Severe aphasia
  • Severe cognitive deficits
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
5 participants (actual)
Patient registry
No

Interventions

  • OtherQualitative interview study

    The group in question is part of a research program aimed at developing and evaluating the LIFANA Nutrition Solution, a meal planning recommended system, which suggests meals based on the user's personal profile. This may include general preferences, such as culture, taste, and budget, but more importantly automated and personalised nutritional recommendations based on advice provided by professional nutritionists and allergists.

    Also known as: Survey

06

What researchers measure

Primary outcomes

  1. User Needs

    The primary endpoint of this study is to explore the perspectives of patients through appropriate adjustments of focus group questions on user needs for managing nutritional status

    Time frame: 1 day/session

07

Study locations

1 site
  • cereneo Schweiz AG
    Vitznau, LU 6354, Switzerland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2018 to primary completion in Oct 2018, 2 months.

Of 62 industry-sponsored observational studies under Stroke, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 58. This study's 2 months is below that.

Counting every sponsor, half of 900 studies reached it within 40 months; a quarter within 18 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2018
First posted
Aug 17, 2018
StartActual
Aug 1, 2018
Primary completionActual
Oct 20, 2018
CompletionActual
Mar 1, 2020
Last update
Jan 27, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03635476
Lead sponsor
Cereneo AG
Collaborators
cereneo Institute for Interdsciplinary Research (cefir)
Responsible party
Krizia Ferrini (Nutritional Specialist, Cereneo AG) — Principal investigator
First posted
Aug 17, 2018
Start date
Aug 1, 2018
Primary completion
Oct 20, 2018
Completion
Mar 1, 2020
Last update
Jan 27, 2021

Study contacts

Krizia Ferrini, PhD
principal investigator · cereneo Schweiz AG | center for neurology & rehabilitation
Doris Mösinger, MSc
study chair · cereneo Schweiz AG | center for neurology & rehabilitation
Leopold Zizlsperger, MD
study director · cereneo Schweiz AG | center for neurology & rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion